InvestorsHub Logo

dead_cat_collector

04/27/15 12:53 PM

#48235 RE: dead_cat_collector #48234

The other reason AMRN might be down is technical. Although I am a technical analysis skeptic, many believe that when a gap appears in a chart, there is a strong tendency to fill it... and we had such a gap roughly between $2 and $2.20 in mid March.

MontanaState83

04/27/15 12:55 PM

#48237 RE: dead_cat_collector #48234

dead-cat - I've seen that over the years as well. But, this is Amarin where good news happens only once every other blue moon with nothing but pain and anguish the rest of the time.

sts66

04/27/15 5:14 PM

#48260 RE: dead_cat_collector #48234

AMGN BD's came out today for their cancer drug/vaccine, Adcom is on Wed, and the BDs apparently point to "this stuff doesn't work, don't approve" - just more bad news pushing down bios today.

zumantu

04/27/15 5:58 PM

#48263 RE: dead_cat_collector #48234

today folks were rudely reminded that some cardiovascular outcomes studies fail... in today's case - a gene therapy for heart failure from Celladon

http://www.thestreet.com/story/13126476/1/gene-therapy-stocks-on-watch-following-failure-of-celladons-heart-failure-trial.html